ID   LAT3_HUMAN              Reviewed;         559 AA.
AC   O75387;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   28-JUN-2023, entry version 164.
DE   RecName: Full=Large neutral amino acids transporter small subunit 3 {ECO:0000305};
DE   AltName: Full=L-type amino acid transporter 3;
DE   AltName: Full=Prostate cancer overexpressed gene 1 protein;
DE   AltName: Full=Solute carrier family 43 member 1;
GN   Name=SLC43A1 {ECO:0000312|EMBL:AAH01639.1};
GN   Synonyms=LAT3 {ECO:0000312|EMBL:BAD00152.1}, PB39
GN   {ECO:0000303|PubMed:9722952}, POV1 {ECO:0000303|PubMed:9722952};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC33004.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RX   PubMed=9722952; DOI=10.1006/geno.1998.5359;
RA   Cole K.A., Chuaqui R.F., Katz K., Pack S., Zhuang Z., Cole C.E., Lyne J.C.,
RA   Linehan W.M., Liotta L.A., Emmert-Buck M.R.;
RT   "cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in
RT   prostate cancer.";
RL   Genomics 51:282-287(1998).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAD00152.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver {ECO:0000312|EMBL:BAD00152.1};
RX   PubMed=12930836; DOI=10.1074/jbc.m305221200;
RA   Babu E., Kanai Y., Chairoungdua A., Kim D.K., Iribe Y., Tangtrongsup S.,
RA   Jutabha P., Li Y., Ahmed N., Sakamoto S., Anzai N., Nagamori S., Endou H.;
RT   "Identification of a novel system L amino acid transporter structurally
RT   distinct from heterodimeric amino acid transporters.";
RL   J. Biol. Chem. 278:43838-43845(2003).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAH01639.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon {ECO:0000312|EMBL:AAH01639.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000305}
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 1).
RX   PubMed=9255310; DOI=10.1016/s0090-4295(97)00194-5;
RA   Chuaqui R.F., Englert C.R., Strup S.E., Vocke C.D., Zhuang Z., Duray P.H.,
RA   Bostwick D.G., Linehan W.M., Liotta L.A., Emmert-Buck M.R.;
RT   "Identification of a novel transcript up-regulated in a clinically
RT   aggressive prostate carcinoma.";
RL   Urology 50:302-307(1997).
RN   [5]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=19443642; DOI=10.1681/asn.2008070809;
RA   Sekine Y., Nishibori Y., Akimoto Y., Kudo A., Ito N., Fukuhara D.,
RA   Kurayama R., Higashihara E., Babu E., Kanai Y., Asanuma K., Nagata M.,
RA   Majumdar A., Tryggvason K., Yan K.;
RT   "Amino acid transporter LAT3 is required for podocyte development and
RT   function.";
RL   J. Am. Soc. Nephrol. 20:1586-1596(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237; SER-262 AND SER-267, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Uniport that mediates the transport of neutral amino acids
CC       such as L-leucine, L-isoleucine, L-valine, and L-phenylalanine
CC       (PubMed:12930836). The transport activity is sodium ions-independent,
CC       electroneutral and mediated by a facilitated diffusion
CC       (PubMed:12930836). {ECO:0000269|PubMed:12930836}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-leucine(in) = D-leucine(out); Xref=Rhea:RHEA:73015,
CC         ChEBI:CHEBI:143079; Evidence={ECO:0000269|PubMed:12930836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-leucine(in) = L-leucine(out); Xref=Rhea:RHEA:73011,
CC         ChEBI:CHEBI:57427; Evidence={ECO:0000269|PubMed:12930836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-isoleucine(in) = L-isoleucine(out); Xref=Rhea:RHEA:70943,
CC         ChEBI:CHEBI:58045; Evidence={ECO:0000269|PubMed:12930836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-methionine(in) = L-methionine(out); Xref=Rhea:RHEA:70939,
CC         ChEBI:CHEBI:57844; Evidence={ECO:0000269|PubMed:12930836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-phenylalanine(in) = L-phenylalanine(out);
CC         Xref=Rhea:RHEA:27950, ChEBI:CHEBI:58095;
CC         Evidence={ECO:0000269|PubMed:12930836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-valine(in) = L-valine(out); Xref=Rhea:RHEA:29703,
CC         ChEBI:CHEBI:57762; Evidence={ECO:0000269|PubMed:12930836};
CC   -!- INTERACTION:
CC       O75387; Q9BYV9: BACH2; NbExp=3; IntAct=EBI-9661945, EBI-1642333;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8BSM7};
CC       Multi-pass membrane protein {ECO:0000255}. Apical cell membrane
CC       {ECO:0000269|PubMed:19443642}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8BSM7}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Located in the apical plasma membrane of the
CC       podocyte foot processes (PubMed:19443642). Located in the plasma
CC       membrane of liver and skeletal muscle, and in the endoplasmic reticulum
CC       and in crystalline inclusions in pancreatic acinar cells (By
CC       similarity). {ECO:0000250|UniProtKB:Q8BSM7,
CC       ECO:0000269|PubMed:19443642}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:9722952}; Synonyms=2.3kb
CC       {ECO:0000303|PubMed:9722952};
CC         IsoId=O75387-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:9722952}; Synonyms=5kb
CC       {ECO:0000303|PubMed:9722952};
CC         IsoId=O75387-2; Sequence=VSP_051620;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in fetus and adult
CC       (PubMed:9722952). Highest expression in adult pancreas, liver, skeletal
CC       muscle (PubMed:9722952, PubMed:12930836). In fetus, highest expression
CC       in liver and lower levels in kidney, and lung (PubMed:12930836).
CC       Exclusively expressed in the glomeruli along the glomerular capillary
CC       walls (PubMed:19443642). {ECO:0000269|PubMed:12930836,
CC       ECO:0000269|PubMed:19443642, ECO:0000269|PubMed:9722952}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in the capillary loop stage and
CC       very faintly in the S-shaped body stage of glomerulus in fetal kidney
CC       of 16 weeks of gestation. {ECO:0000269|PubMed:19443642}.
CC   -!- SIMILARITY: Belongs to the SLC43A transporter (TC 2.A.1.44) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF045584; AAC33004.1; -; mRNA.
DR   EMBL; AB103033; BAD00152.1; -; mRNA.
DR   EMBL; BC001639; AAH01639.1; -; mRNA.
DR   CCDS; CCDS7958.1; -. [O75387-1]
DR   RefSeq; NP_001185739.1; NM_001198810.1. [O75387-1]
DR   RefSeq; NP_003618.1; NM_003627.5. [O75387-1]
DR   RefSeq; XP_016873940.1; XM_017018451.1.
DR   AlphaFoldDB; O75387; -.
DR   BioGRID; 114073; 16.
DR   DIP; DIP-47272N; -.
DR   IntAct; O75387; 6.
DR   MINT; O75387; -.
DR   STRING; 9606.ENSP00000278426; -.
DR   BindingDB; O75387; -.
DR   ChEMBL; CHEMBL4148; -.
DR   TCDB; 2.A.1.44.1; the major facilitator superfamily (mfs).
DR   GlyCosmos; O75387; 3 sites, No reported glycans.
DR   GlyGen; O75387; 3 sites.
DR   iPTMnet; O75387; -.
DR   PhosphoSitePlus; O75387; -.
DR   SwissPalm; O75387; -.
DR   BioMuta; SLC43A1; -.
DR   EPD; O75387; -.
DR   jPOST; O75387; -.
DR   MassIVE; O75387; -.
DR   MaxQB; O75387; -.
DR   PaxDb; O75387; -.
DR   PeptideAtlas; O75387; -.
DR   ProteomicsDB; 49960; -. [O75387-1]
DR   ProteomicsDB; 49961; -. [O75387-2]
DR   Antibodypedia; 14174; 130 antibodies from 23 providers.
DR   DNASU; 8501; -.
DR   Ensembl; ENST00000278426.8; ENSP00000278426.3; ENSG00000149150.9. [O75387-1]
DR   Ensembl; ENST00000528450.5; ENSP00000435673.1; ENSG00000149150.9. [O75387-1]
DR   GeneID; 8501; -.
DR   KEGG; hsa:8501; -.
DR   MANE-Select; ENST00000278426.8; ENSP00000278426.3; NM_003627.6; NP_003618.1.
DR   UCSC; uc001nkk.4; human. [O75387-1]
DR   AGR; HGNC:9225; -.
DR   CTD; 8501; -.
DR   DisGeNET; 8501; -.
DR   GeneCards; SLC43A1; -.
DR   HGNC; HGNC:9225; SLC43A1.
DR   HPA; ENSG00000149150; Group enriched (liver, pancreas).
DR   MIM; 603733; gene.
DR   neXtProt; NX_O75387; -.
DR   OpenTargets; ENSG00000149150; -.
DR   PharmGKB; PA33549; -.
DR   VEuPathDB; HostDB:ENSG00000149150; -.
DR   eggNOG; ENOG502QUZ1; Eukaryota.
DR   GeneTree; ENSGT00940000153576; -.
DR   HOGENOM; CLU_035676_0_0_1; -.
DR   InParanoid; O75387; -.
DR   OMA; INWPRES; -.
DR   OrthoDB; 5384516at2759; -.
DR   PhylomeDB; O75387; -.
DR   TreeFam; TF328358; -.
DR   PathwayCommons; O75387; -.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   SABIO-RK; O75387; -.
DR   SignaLink; O75387; -.
DR   BioGRID-ORCS; 8501; 17 hits in 1159 CRISPR screens.
DR   ChiTaRS; SLC43A1; human.
DR   GeneWiki; SLC43A1; -.
DR   GenomeRNAi; 8501; -.
DR   Pharos; O75387; Tbio.
DR   PRO; PR:O75387; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; O75387; protein.
DR   Bgee; ENSG00000149150; Expressed in body of pancreas and 125 other tissues.
DR   ExpressionAtlas; O75387; baseline and differential.
DR   Genevisible; O75387; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098846; C:podocyte foot; IDA:UniProtKB.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015188; F:L-isoleucine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015190; F:L-leucine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005304; F:L-valine transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015175; F:neutral L-amino acid transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0015818; P:isoleucine transport; IDA:UniProtKB.
DR   GO; GO:1903785; P:L-valine transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0015820; P:leucine transport; IDA:UniProtKB.
DR   GO; GO:0051956; P:negative regulation of amino acid transport; IDA:ARUK-UCL.
DR   GO; GO:0060358; P:negative regulation of leucine import; IDA:ARUK-UCL.
DR   GO; GO:0015804; P:neutral amino acid transport; IDA:UniProtKB.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   PANTHER; PTHR20766; -; 1.
DR   PANTHER; PTHR20766:SF0; LARGE NEUTRAL AMINO ACIDS TRANSPORTER SMALL SUBUNIT 3; 1.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Cell membrane;
KW   Endoplasmic reticulum; Glycoprotein; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..559
FT                   /note="Large neutral amino acids transporter small subunit
FT                   3"
FT                   /id="PRO_0000218640"
FT   TRANSMEM        20..40
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        78..98
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        105..124
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        131..151
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        168..188
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        191..211
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        304..324
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        357..377
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        419..439
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        446..466
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        485..505
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        510..530
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         237
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        212
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        229
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         513..559
FT                   /note="NLGLLLFSLLGFLLPSYLFYYRARLQQEYAANGMGPLKVLSGSEVTA -> R
FT                   ARVGVGGAGATLLGAGVGPCMWCHPSLISARGTSEVSNLQVSKLSAF (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:9722952"
FT                   /id="VSP_051620"
FT   VARIANT         238
FT                   /note="G -> V (in dbSNP:rs17151933)"
FT                   /id="VAR_053670"
FT   VARIANT         443
FT                   /note="H -> Y (in dbSNP:rs34746107)"
FT                   /id="VAR_053671"
SQ   SEQUENCE   559 AA;  61477 MW;  49B0DECA3D930A45 CRC64;
     MAPTLQQAYR RRWWMACTAV LENLFFSAVL LGWGSLLIIL KNEGFYSSTC PAESSTNTTQ
     DEQRRWPGCD QQDEMLNLGF TIGSFVLSAT TLPLGILMDR FGPRPVRLVG SACFTASCTL
     MALASRDVEA LSPLIFLALS LNGFGGICLT FTSLTLPNMF GNLRSTLMAL MIGSYASSAI
     TFPGIKLIYD AGVAFVVIMF TWSGLACLIF LNCTLNWPIE AFPAPEEVNY TKKIKLSGLA
     LDHKVTGDLF YTHVTTMGQR LSQKAPSLED GSDAFMSPQD VRGTSENLPE RSVPLRKSLC
     SPTFLWSLLT MGMTQLRIIF YMAAVNKMLE YLVTGGQEHE TNEQQQKVAE TVGFYSSVFG
     AMQLLCLLTC PLIGYIMDWR IKDCVDAPTQ GTVLGDARDG VATKSIRPRY CKIQKLTNAI
     SAFTLTNLLL VGFGITCLIN NLHLQFVTFV LHTIVRGFFH SACGSLYAAV FPSNHFGTLT
     GLQSLISAVF ALLQQPLFMA MVGPLKGEPF WVNLGLLLFS LLGFLLPSYL FYYRARLQQE
     YAANGMGPLK VLSGSEVTA
//
